Legislation impacting pharmacy benefits
Optum Rx closely monitors and acts to influence legislation that has the potential to adversely impact pharmacy benefits offered by both fully insured and self-insured clients. The most recent updates are available below. Check back on a quarterly basis for the latest legislative updates.
Regulations to watch: Spring 2025
Learn what’s at stake for pharmacy benefit sponsors as federal oversight changes and state legislative sessions begin.
- As new administration takes over, PBM reform provisions left out of federal funding extension
- Standalone PBM legislation at federal level remains a possibility
- CMS issues 2026 Medicare Part C and Part D Final Rule
- At state level, more than 1,250 bills impacting prescription drugs active, twice previous year’s total
Related healthcare insights
Article
In this conversation, learn the implications of new pharmacy legislation and rulemaking, and how you can manage your benefits effectively.
Article
An assessment of the latest rules impacting PBMs from state and federal legislation.
Article
Get your guide to the evolving health care regulatory landscape and see what’s coming as lawmakers debate 600+ new bills impacting PBMs.